Efgartigimod for generalized myasthenia gravis in the extreme elderly (≥80 years): a multicenter retrospective real-world study
埃夫加替莫德治疗极高龄(≥80岁)重症肌无力患者的多中心回顾性真实世界研究
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1685233
Hong, Ye; Yuan, Chang-Wen; Lu, Jie; Kong, Ping-Ping; Huang, Shi-Qi; Yang, Rui-Yuan; Yuan, Zhen-Hua; Zhao, Hong-Dong; Jiang, Teng; Chen, Jing; Shi, Jian-Quan